Amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dih ydro-2H-chromen-6-yl derivatives, process and intermediate products for their preparation and medicaments containing these compounds

Details for Australian Patent Application No. 2004281195 (hide)

Owner Solvay Pharmaceuticals GmbH

Inventors Moloney, Brian; Weske, Michael; Sykes, David; Fischer, Yvan; Mlinaric, Michael; Boecker, Christiane; Brueckner, Reinhard; Witte, Klaus; Marrison, Lester; Ziegler, Dieter

Agent Watermark

Pub. Number AU-B-2004281195

PCT Pub. Number WO2005/037780

Priority 103 48 298.9 17.10.03 DE

Filing date 14 October 2004

Wipo publication date 28 April 2005

Acceptance publication date 16 December 2010

International Classifications

C07D 307/00 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

A61K 31/353 (2006.01)

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

C07D 311/00 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

C07D 311/68 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

C07D 407/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/037780 Priority application(s): WO2005/037780

6 July 2006 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 01 Jun 2006

6 November 2008 Amendment Made

  The nature of the amendment is: Amend the invention title to read from Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2H-chromium-6-yl-derivatives and drugs containing said compounds to Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2H-chromem-6-yl-derivatives and drugs containing said compounds

27 November 2008 Amendment Made

  The nature of the amendment is: Amend the invention title to read Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2H-chromen-6-yl-derivatives, process and intermediate products for their preparation and medicaments containing these compounds

18 June 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl-derivative s, process and intermediate products for their preparation and medicaments containing these compounds

2 July 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl derivatives, process and intermediate products for their preparation and medicaments containing these compounds

16 December 2010 Application Accepted

  Published as AU-B-2004281195

14 April 2011 Standard Patent Sealed

10 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004281214-Derivatives of N- ``phenyl(piperidine-2-yl) methyl benzamide, preparation method thereof and applications of same in therapeutics

2004281193-Water filter manifold with integral valve